Table 4.

Association between autotaxin and cardiometabolic risk factors at 12 months

	All		Men		Women
Number of participants	69		20		49
	r	P	r	P	r	P
Age	−0.01	0.93	0.13	0.58	0.09	0.53
Body weight	−0.15	0.22	0.39	0.09	0.05	0.73
BMI	0.09	0.46	0.37	0.11	0.07	0.65
Fat percent	0.28	0.02	0.30	0.20	−0.10	0.50
Fat mass	0.15	0.21	0.29	0.21	−0.03	0.82
Fat‐free mass	−0.30	0.01	0.21	0.39	0.14	0.33
Apo B	0.25	0.04	0.20	0.39	0.23	0.12
LDL‐C	0.22	0.06	0.28	0.23	0.12	0.41
HDL‐C	0.09	0.46	−0.25	0.29	−0.02	0.88
Triglycerides	0.20	0.09	−0.08	0.73	0.31	0.03
Insulin	0.11	0.37	0.12	0.62	0.21	0.14
Glucose	0.006	0.96	0.36	0.12	0.08	0.60
HbA1c	0.03	0.82	0.07	0.77	0.09	0.56
HOMA‐IR	0.10	0.41	0.16	0.49	0.21	0.16
Adiponectin	0.07	0.56	−0.04	0.88	0.06	0.66
Leptin	0.27	0.03	0.08	0.74	0.09	0.52

LDL: low‐density lipoprotein; HDL: high‐density lipoprotein; HOMA‐IR: homeostatic model of insulin resistance; HbA1c: glycated hemoglobin.

P‐values indicate statistically significant correlations (P < 0.05) in bold.